Skip to main content

Vaccine

  • Chapter
  • First Online:
Basic and Applied Aspects of Biotechnology

Abstract

Humans have tried to fight diseases by the usage of vaccines. Vaccination is a powerful and cost-effective weapon for the prevention of diseases. Because of worldwide vaccination programs, the humans have not only successfully used vaccines to get rid of many childhood diseases but also some of the diseases like smallpox are completely eradicated. Any preparation of virus, bacteria, or their subunits, which is able to impart protection in the individual in which they are administered by activating the immune system, is known as vaccine. As immunization drive starts from childhood therefore it has substantially lowered the morbidity and mortality of children from many infectious diseases.

Vaccination is a mode of active immunization in which attenuated live microorganism or killed microorganism or its specific component is administered in humans. Following exposure to modified pathogenic agent (not able to harm and cause diseases in humans), the immune system is activated. Immune systems’ innate and adaptive branches effectively neutralize the pathogenic agents and its T and B cells owing to their memory response remember their first encounter with the pathogen. Upon subsequent encounter in the due course of time with the same agent, the immune systems’ adaptive branch (T- and B-cell response) effectively and quickly mounts a heightened response and facilitates antigen clearance from the body.

However, despite of tremendous developments in science and technology, some diseases (AIDS, malaria, multiple drug-resistant TB, leishmaniasis) are still big challenges for which we do not have effective vaccines. Vaccines need to be developed for these diseases, which are cause of millions of death worldwide. The chapter is designed to give the insights about the properties of vaccines, adjuvants, attenuated, inactivated, subunit, and nucleic acids as vaccines. This also covers edible vaccines, vaccination for cancer, reverse vaccinology, and generation of vaccines.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Abbas AK, Lichtman AH (2009) Basic immunology, 3rd edn. Saunders Elsevier, Philadelphia

    Google Scholar 

  2. Alm, Gunner V (2003) Role of natural interferon-alpha producing cells (plasmacytoid dendritic cells) in autoimmunity. Autoimmunity 36:463–472

    Article  Google Scholar 

  3. Decatris, Marios (2002) Potential of interferon-alfa in solid tumours. Biodrugs 16:261–268

    Article  CAS  Google Scholar 

  4. Doorbar J (2006) Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci 110:525–541

    Article  CAS  Google Scholar 

  5. Fleur NS (2015) Inhaled ebola vaccine stops virus in monkeys, Study finds. The New York Times (July 13)

    Google Scholar 

  6. Goodsell, David S (2001) The molecular perspective: interferon. Oncologist 6:374–375

    Article  CAS  Google Scholar 

  7. IIchmann K et al (n.d.) Vaccine development & the BWC. http://hsp.sussex.ac.uk/sandreviews/

  8. Kindt TJ, Goldsby RA, Osborne B (2007) KUBY immunology, 6th edn. Freeman and Company, New York

    Google Scholar 

  9. Kit Y-Y, Semenov DV, Nevinsky GA (1996) Phosphorylation of different human milk proteins by human catalytic secretory immunoglobulin A. Biochem Mol Biol Int 39:521–527

    CAS  Google Scholar 

  10. Korban SS, Krasnyanski SF, Buetow DE (2002) Foods as production and delivery vehicles for human vaccines. J Am Coll Nutr 21:212S–217S

    Article  Google Scholar 

  11. Krensky AM, Flavio V, Bennett WM (n.d.) Chapter 52. Immunosuppressants, tolerogens, and immunostimulants. In: Brunton LL, Lazo JS, Parker KL (eds) Goodman & Gilman’s the pharmacological basis of therapeutics, 11th edn: http://www.accessmedicine.com/content.aspx?aID=951722

  12. Liu M (2011) DNA vaccines: an historical perspective and view to the future. Immunol Rev 239:62–84

    Article  CAS  Google Scholar 

  13. Lollini PL, Cavallo F, Nanni P, Forni G (2006) Vaccines for tumour prevention. Nat Rev Cancer 6:204–216

    Article  CAS  Google Scholar 

  14. Lowy DR, Schiller JT (2006) Prophylactic human papillomavirus vaccines. J Clin Invest 116:1167–1173

    Article  CAS  Google Scholar 

  15. Moriel DG, Scarselli M, Serino L, Mora M, Rappuoli R, Masignani V (2008) Genome-based vaccine development a short cut for the future. Hum Vaccin 4:184–188

    Article  CAS  Google Scholar 

  16. Parkin DM (2006) The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118:3030–3044

    Article  CAS  Google Scholar 

  17. Scheibner V (1993) Vaccinations 100 years of orthodox research. New Altantean Press, Santa Fe

    Google Scholar 

  18. Semiromi AD, Samson N, Daniell H (2009) The green vaccine: a global strategy to combat infectious and autoimmune diseases. Hum Vaccine 5:488–493

    Article  Google Scholar 

  19. U.S. Centers for Disease Control and Prevention (2005) A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part 1: immunization of infants, children, and adolescents. Morb Mortal Wkly Rep 54(No. RR–16):1–31

    Google Scholar 

  20. World Health Organisation (2006) Development of new vaccines. Fact Sheet no 289, Revised December 2006

    Google Scholar 

Some Selected Resources

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media Singapore

About this chapter

Cite this chapter

Gupta, V., Sengupta, M., Prakash, J., Tripathy, B.C. (2017). Vaccine. In: Basic and Applied Aspects of Biotechnology. Springer, Singapore. https://doi.org/10.1007/978-981-10-0875-7_14

Download citation

Publish with us

Policies and ethics